| J9271 | Injection, pembrolizumab, 1 mg | 9,200 | $40 | $395.6K |
| J0897 | Injection, denosumab, 1 mg | 4,440 | $20 | $79.9K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,650 | $30 | $56.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 510 | $90 | $46.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 370 | $100 | $37.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 580 | $60 | $36.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,040 | $1 | $20.1K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 190 | $90 | $17.1K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 90 | $180 | $16.4K |
| J0185 | Injection, aprepitant, 1 mg | 14,950 | $1 | $14.9K |